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Introduction
Neuromyelitis optica (NMO) is an inflammatory disorders 
characterized by repeated exacerbation and remission of 
severe optic neuritis and transverse myelitis.1 Transverse 
myelitis often leads to a flaccid paralysis along the area of 
inflammation. Physical therapy is one treatment for NMO. 
However, there are only few reports regarding physical ther-
apy for NMO,2,3 and no published studies have focused on 
the safety of physical therapy during the acute phase. This 
article reports an instance of acute phase physical therapy in 
a patient with NMO.
Case
The patient was a 32-year-old female with NMO diag-
nosed by magnetic resonance imaging (MRI) who had a 
T2-weighted hyperintense lesion in the central cord from 
C2 to T2 (Figure 1) and was positive for serum anti-aqua-
porin-4 antibodies. Written informed consent was obtained 
from the patient for her anonymized data to be published 
in this article. The patient visited our hospital because of 
left hemiplegia and limb sensory disorder. Upon admis-
sion to the hospital, her Expanded Disability Status Scale 
(EDSS) score,4 Medical Research Council (MRC) score 
for muscle strength score,5 and sensory score (according 
with American Spinal Injury Association sensory 
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assessment)6 were 9.0, 37, and 158, respectively. She had 
paralysis and decrease muscle tone in the left side of her 
body (mainly in the lower limb, L1−S5 region), but no 
respiratory and pain problem. The clinical chart of the 
medical treatment, rehabilitation program, and clinical 
improvement is shown in Figure 2. The patient underwent 
treatment by steroid pulse therapy (methylprednisolone 
1000 mg/day, days 2–4, and days 6–8). In addition, plasma 
exchange (plasma volume = 60 mL/kg/day, days 10, 13, 
16, 18, and 20) was performed five sessions and intrave-
nous immunoglobulin (dosage = 0.4 g/kg/day, days 24, 
25, 26, 27, and 28) was administered five times (Figure 
2(a)). Prednisolone was taken orally 20 mg/day as post-
therapy. The patient commenced physical therapy on day 
4. During the first physical therapy evaluation, her gen-
eral status was lucid and her left-side limb muscle strength 
(i.e. paralysis side) was approximately grade 1–2 by a 
manual muscle test (MMT). She started a standing exer-
cise and muscle strength training immediately. Physical 
therapy was performed 5 days/week for 60 min. The mus-
cle strength training started with isotonic movements 
(shoulder flexion, hip flexion, and knee extension). The 
paralyzed muscles received electrical muscle stimulation 
(EMS) using an EMS device (AUTO Tens PRO Rehabili 
Unit; Homer Ion Co. Ltd., Tokyo, Japan). We performed 
EMS at 20 Hz with a monophasic square-wave pulse with 
a duration of 250 µs, an on time of 5 s, an off time of 2 s, 
no rise time, and decay using the EMS device. Belt elec-
trodes were used for skeletal muscle stimulation. The 
electrodes were wrapped around the waist, distal parts of 
the thigh, and the crus of the paralyzed side (Figure 3). 
Each exercise was performed without exceeding 17 on the 
15-point Borg scale. Furthermore, she was carried out 
gait practice step by step as the spasticity improved. She 
performed a locomotion exercise using a walker and 
knee-ankle-foot orthosis from day 14. She also started 
locomotion using an elbow crutch and foot orthosis with-
out assistance from day 24. She was subsequently trans-
ferred to a rehabilitation hospital on day 34 because her 
overall condition had improved and she had completed 
treatment in the acute phase. Her left-side limb muscle 
strength improved to approximately grade 4 by the MMT, 
with improvements in the EDSS score (from 9.0 to 6.0), 
MRC muscle strength score (from 37 to 54), sensory score 
(from 152 to 203), and all functional independence meas-
ure dominants compared with the respective values 
on admission (Tables 1–3). She did not experience wors-
ening of the symptoms (e.g. pain and spasticity) during 
hospitalization.
Discussion
In this study, we performed intensive rehabilitation from 
the inflammatory phase in a patient with NMO. To our 
knowledge, there are no previous reports on the safety of 
physical therapy in patients with NMO during the acute 
phase. However, it has been considered that the perfor-
mance of exercise during the acute phase of the disease 
can lead to deterioration of the patient’s symptoms. 
Nevertheless, intensive physical therapy has recently 
been shown to have positive effects in patients with 
inflammatory myopathies.7,8 This study showed that a 
physical therapy program did not exacerbate symptoms 
in a patient with NMO when performed cautiously based 
on the patient’s degree of subjective fatigue and muscle 
pain. Therefore, we consider that a carefully supervised 
physical therapy program can be applied safely and 
effectively in patients with NMO, as well as in patients 





Figure 1. Spinal cord MRI in the acute phase. The sagittal plane (a) and axial plane (b) of T2-weight hyperintense lesion in the central cord.
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In most cases of NMO, treatment in the acute phase does 
not involve physical therapy until medical treatment has been 
completed. In this situation, many patients with NMO must 
stay in bed for 1–2 weeks. Previous studies have revealed that 
the bed rest leads to muscle disuse atrophy.10,11 It has further 
been reported that muscle atrophy can even occur in healthy 
people, and may be apparent after only 5 to 10 days.10–12 In 
recent studies, early physical therapy with medication resulted 
in effective physical outcomes in patients with several dis-
eases, as long as the therapy was performed cautiously and 
was supervised by a medical doctor and/or physical thera-
pist.7,13 Therefore, starting physical therapy during the acute 
phase may also be important in patients with NMO. However, 
there are no reports on physical therapy in patients with NMO 
in the acute phase. In future research, it is necessary to 
increase the number of patients and consider the safety of 
physical therapy in the acute phase.
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Figure 3. Belt electrodes were wrapped around the waist, distal 
parts of the thigh, and the crus of the paralyzed side. The waist 
electrode had a width of 5.5 cm and a length of 40 cm twice (a), 
the thigh electrode had a width 5.5 cm and a length 54 cm (b), 
and the crus electrode had a width 5.5 cm and a length 31 cm (c).
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Conclusion
We described a physical therapy program in a case of 
hemiplegia and sensory disorder caused by NMO. This 
study showed that a carefully supervised physical therapy 
program did not cause deterioration of the patient’s 
symptoms.
Table 2. Medical Research Council scale for muscle strength 
score.
Muscle Admission Discharge
Shoulder abductors Left 1 4
Right 5 5
Elbow flexors Left 1 4
Right 5 5
Wrist extensors Left 2 4
Right 5 5
Hip flexors Left 1 4
Right 5 5
Knee extensors Left 1 4
Right 5 5
Foot dorsiflexors Left 1 4
Right 5 5
Total (out of 60) 37 54
Table 1. The functional independence measurement score.
FIM domains Admission score Discharge score
Self-care
 Feeding 5 6
 Grooming 4 6
 Bathing 4 6
 Upper extremity dressing 4 6
 Lower extremity dressing 4 6
 Toileting 3 6
Sphincter control
 Bladder 3 6
 Bowel 3 6
Transfer
 Bed, chair, wheel chair 4 6
 Toilet 4 6
 Tub, shower 1 5
Locomotion
 Walk/wheelchair 1 4
 Stair 1 4
Communication
 Comprehensive 7 7
 Expression 6 7
Social cognition
 Social interaction 7 7
 Problem-solving 7 7
 Memory 7 7
Total 75 108
FIM: functional independence measure.










C2 Left 2 2 2 2
Right 2 2 2 2
C3 Left 1 1 2 2
Right 2 2 2 2
C4 Left 1 1 2 2
Right 2 2 2 2
C5 Left 1 1 2 2
Right 2 2 2 2
C6 Left 1 1 2 2
Right 2 2 2 2
C7 Left 1 1 2 2
Right 2 2 2 2
C8 Left 1 1 2 2
Right 2 2 2 2
T1 Left 1 1 1 2
Right 2 2 2 2
T2 Left 1 1 1 2
Right 2 2 2 2
T3 Left 1 1 1 2
Right 2 2 2 2
T4 Left 1 1 1 2
Right 2 2 2 2
T5 Left 1 1 1 2
Right 2 2 2 2
T6 Left 1 1 1 2
Right 2 2 2 2
T7 Left 1 1 1 2
Right 2 2 2 2
T8 Left 1 1 1 2
Right 2 2 2 2
T9 Left 1 1 1 2
Right 2 2 2 2
T10 Left 1 1 1 2
Right 2 2 2 2
T11 Left 1 1 1 2
Right 2 2 2 2
T12 Left 1 1 1 2
Right 2 2 2 2
L1 Left 0 0 1 2
Right 2 2 2 2
L2 Left 0 0 1 2
Right 2 2 2 2
L3 Left 0 0 1 2
Right 2 2 2 2
L4 Left 0 0 1 2
Right 2 2 2 2
L5 Left 0 0 1 2
Right 2 2 2 2
S1 Left 0 0 1 2
Right 2 2 2 2
(Continued)
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S2 Left 0 0 1 2
Right 2 2 2 2
S3 Left 0 0 1 2
Right 2 2 2 2
S4-
5
Left 0 0 1 2
Right 2 2 2 2
Total 152 203
0: absent; 1: altered; 2: normal.
Table 3. (Continued)
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